Kemwell

Pharmaceutical Contract Development, Manufacturing, Packaging and Distribution

Cirrus to Launch Clinical Trial Manufacturing at Raleigh-Durham Site

Cirrus Pharmaceuticals has announced it is ready to launch its services for manufacturing cGMP materials for early phase clinical trials in its state-of-the-art flexi-suite at its...

Cirrus to Launch Clinical Trial Manufacturing at Raleigh-Durham Site

Kemwell Wins Awards at CMO Leadership Awards

Kemwell has won multiple awards at the CMO Leadership...

Kemwell Wins Awards at CMO Leadership Awards

Kemwell Announces Successful FDA Inspection

Kemwell Biopharma has announced that its oral solids manufacturing facility in Bangalore, India has successfully completed its second US Food and Drug Administration (FDA)...

Kemwell Announces Successful FDA Inspection

Cirrus Pharmaceuticals to Invest in cGMP Manufacturing Suite in US

Cirrus Pharmaceuticals has announced it will be investing in a flexible current good manufacturing practice (cGMP) suite in its facility in Research Triangle Park (RTP), North...

Cirrus Pharmaceuticals to Invest in cGMP Manufacturing Suite in US

New CEO of Swedish Operations Announced by Kemwell AB

Kemwell AB, part of the Kemwell group, which is a contract pharmaceutical development and manufacturing company with facilities in Sweden, India and the US, has announced the appointment of...

New CEO of Swedish Operations Announced by Kemwell AB

Mikael Ericson Will Be New CEO of Kemwell’s Swedish Operations

Mikael Ericson will be the new CEO of Kemwell's Swedish...

Mikael Ericson Will Be New CEO of Kemwell’s Swedish Operations

Kemwell Announces Successful EMA Renewal Audit

Kemwell Biopharma has completed a current good manufacturing practice (cGMP) joint audit of its oral solids manufacturing facility in Bangalore,...

Kemwell Announces Successful EMA Renewal Audit

Lyophilization Capability Added by Kemwell

Kemwell Biopharma has announced it has installed and qualified its commercial-scale...

Lyophilization Capability Added by Kemwell

Siddharth J Advant is the New President of Biopharmaceutical Services

Siddharth J Advant, PhD, is the new president of its biopharmaceutical...

Siddharth J Advant is the New President of Biopharmaceutical Services

Kemwell Receives Grant from US FDA

Cirrus Pharmaceuticals has been awarded a grant by the US Food and Drug Administration for evaluating formulation effects on MDI...

Kemwell Receives Grant from US FDA